Cardiovascular efficacy of sitagliptin in patients with diabetes at high risk of cardiovascular disease: a 12-month follow-up
Next scheduled review date: 6 July 2029 More on this topic What Is Off-Label Prescribing
With enhanced energy levels, you can push through intense training sessions, unlocking your full potential and making every workout count
No established contraindication is documented for glutathione supplementation in fatty liver disease, but the evidence base is limited and glutathione products are unlicensed medicines in the UK
Other conditions that have been associated with MetS are strongly related with insulin resistance and adiposity, namely, non-alcoholic fatty liver disease (NAFLD), polycystic ovarian syndrome, obstructive sleep apnoea (OSA), hypogonadism, lipodystrophy, and microvascular disease
Together, we can determine the best path forward to help you live a healthier, happier life